Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical and Genomic Registry of Myelodysplastic Syndrome (MDS) and Secondary Acute Myeloid Leukaemia (AML) in Asia

NCT03169296 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.

NCT NCT03169296
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03169296 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical and Genomic Registry of Myelodysplastic Syndrome (MDS) and Secondary Acute Myeloid Leukaemia (AML) in Asia
Lead sponsor
The University of Hong Kong
Phase
Observational
Overall status
Unknown status
Start date
May 8, 2017
Completion date
December 30, 2023
Enrollment
2,600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myelodysplastic syndromes